Haemophilus Infection
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ (NCT00802867) | Sanofi Pasteur, a Sanofi Company | 2004-02-01 |
| Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ (NCT00772928) | Sanofi | 2003-10-01 |
| Retrospective Survey of Safety of Fourth Dose Pentacel® in Children (NCT00772369) | Sanofi Pasteur, a Sanofi Company | 2003-09-01 |
Track Haemophilus Infection automatically
Every clearance here is in the API, with alerts when new ones post.